| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.031 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |